The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The “RENAISSANCE” Trial: Effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction—A phase III trial of the German AIO/CAO-V/CAOGI.
 
Daniel Wilhelm Mueller
No Relationships to Disclose
 
Stefan Paul Moenig
Consulting or Advisory Role - Lilly
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Sylvie Lorenzen
No Relationships to Disclose
 
Nils Homann
Consulting or Advisory Role - Amgen; Celgene; Lilly; Roche; Sanofi
 
Christoph Reissfelder
No Relationships to Disclose
 
Claus Bolling
No Relationships to Disclose
 
Wolfgang Blau
No Relationships to Disclose
 
Wolff H. Schmiegel
Consulting or Advisory Role - 4SC; AiCuris; Amgen; Apceth; AstraZeneca; Indivumed; Merck Serono; Roche
Research Funding - see link: http://www.medunikkh.de/aerzte/studien/ (Inst)
Patents, Royalties, Other Intellectual Property - Biomarker für die Diagnose von Pankreaskrebs Internationale Patentanmeldung PCT/DE2007/002174 Anmelder: Prof. Dr. Schmiegel, Prof. Dr. S. Hahn, Prof. Dr. H.E. Meyer, Dr. Sitek, Dr. K. Stühler, Dr. Bence-Sipos, Prof. Dr. Klöppel, Dr. Alkatout; Biomarker für hepatische Fibrose Patentanmeldung Deutschland: DE 10 2006 048249.2. Internationale Patentanmeldung PCT/DE 2007001427 Anmelder: Prof. Dr. W. Schmiegel, Dr. C. Mölleken, Dr. Bence-Sipos, Prof. Dr. Klöppel, Prof. Dr. H.E. Meyer, Dr. K. Stühl; Buproprion – Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C Patentanmeldung Deutschland: DE 10 2004 063 132.8-41 Anmelder: Prof. Dr. W. Schmiegel; Diagnoseverfahrung und Verwendung von MicroRNA Patentanmeldung Deutschland 10 2010 046 866.5 Anmelder: Dr. A. Baraniskin, Prof. Dr. U. Schlegel, Prof. Dr. W. Schmiegel, PD Dr. R. Schroers; Immunoscreening of the Extracellular Proteome of Colorectal Cancer Cells Patentanmeldung USA US 61/176,353 Anmelder: Prof. Dr. W. Schmiegel, Prof. Dr. H.E. Meyer; Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor und Darmkrebs Internationale Patentanmeldung: PCT/DE2008/001220 Anmelder: Hanna Diehl, Dr. Kai Stühler, Prof. Dr. H. E. Meyer, Dr. S. Klein-Scory, PD Dr. I. Schwarte-Waldho; Pantumormarker Patentanmeldung Deutschland 10 2011 108 254.2 Anmelder: Prof. Dr. W. Schmiegel, Prof. Dr. Stephan Hahn, Dr. Alexander Baraniskin; Statine/HMG-CoA Reduktase Hemmer zur Herstellung von Mitteln, die sich zur Primär- und Sekundärprävention sowie zur Behandlung von hyperplastischen oder dysplastischen Dickdarmpolypen eignen. Patentanmeldung Deutschland DE 10 2004 036 907.0-41 Anmelder:
Travel, Accommodations, Expenses - Abbott; Deutscher Ärzteverlag; Dres. Schlegel + Schmidt; Falk Foundation; GSB Pharma; Labor Berlin-Charité Vivantes Services GmbH; Lilly; MedCongress; Merck Serono; Miami Cancer Institute; Pfizer; Roche; Sanofi; Siemens Healthineers
 
Patrick Michl
Honoraria - Ipsen; Novartis; Roche
Consulting or Advisory Role - Lilly
Research Funding - Halozyme; Ipsen; Lilly
 
Karel Caca
No Relationships to Disclose
 
Matthias Schwarzbach
No Relationships to Disclose
 
Ralf Hofheinz
No Relationships to Disclose
 
Claus Roedel
No Relationships to Disclose
 
Manish A. Shah
Consulting or Advisory Role - Lilly
Research Funding - Gilead Sciences (Inst); Lilly/ImClone (Inst); Merck (Inst); Sanofi/Regeneron (Inst)
 
Mitsuru Sasako
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Wolf O. Bechstein
No Relationships to Disclose
 
Hauke Lang
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Roche; SERVIER
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma